Open Access

Clinical Characteristics of Premenstrual Syndrome/Premenstrual Dysphoric Disorder Co-Morbid with Panic Disorder and the Effectiveness of Selective Serotonin Reuptake Inhibitors in Its Treatment


Cite

1. Pearlstein TB, Frank E, Rivera-Tovar A, Thoft JS, Jacobs E, Mieczkowski TA. Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder. J Affect Disord. 1990;20(2):129-34.10.1016/0165-0327(90)90126-SSearch in Google Scholar

2. Chandraiah S, Levenson JL, Collins JB. Sexual dysfunction, social maladjustment, and psychiatric disorders in women seeking treatment in a premenstrual syndrome clinic. Int J Psychiatry Med. 1991;21(2):189-204.10.2190/A4JM-PGR9-35PH-4WCWSearch in Google Scholar

3. Stout AL, Steege JF, Blazer DG, George LK. Comparison of lifetime psychiatric diagnoses in Premenstrual Syndrome Clinic and community samples. J Nerv Ment Dis. 1986;174(9):517-22.10.1097/00005053-198609000-00002Search in Google Scholar

4. Harrison WM, Endicott J, Nee J, Glick H, Rabkin JG. Characteristics of women seeking treatment for premenstrual syndrome. Psychosomatics. 1989;30(4):405-11.10.1016/S0033-3182(89)72246-5Search in Google Scholar

5. Fava M, Pedrazzi F, Guaraldi GP, Romano J, Genazzani AR, Facchinett F. Comorbid anxiety and depression among patients with late luteal phase dysphoric disorder. J Anx Disord. 1992;6(4):325-35.10.1016/0887-6185(92)90004-QSearch in Google Scholar

6. Cameron OG, Kuttesch D, McPhee K, Curtis GC. Menstrual fluctuation in the symptoms of panic anxiety. J Affect Disord. 1988;15:169-74.10.1016/0165-0327(88)90086-9Search in Google Scholar

7. Cook BL, Noyes R, Garvey MJ, Beach V, Sobotka J, Chaudhry D. Anxiety and the menstrual cycle in panic disorder. J Affect Disord. 1990;19(3):221-6.10.1016/0165-0327(90)90095-PSearch in Google Scholar

8. Stein MB, Schmidt PJ, Rubinow DR, Uhde TW. Panic disorder and the menstrual cycle: panic disorder patients, healthy control subjects, and patients with premenstrual syndrome. Am J Psychiatry. 1989;146(10):1299-303.10.1176/ajp.146.10.1299Search in Google Scholar

9. Kaspi S, Otto MW, Pollack MH, Eppinger S, Rosenbaum JF. Premenstrual exacerbation of symptoms in women with panic disorder. J Anx Disord. 1994;8(2):131-8.10.1016/0887-6185(94)90011-6Search in Google Scholar

10. Vickers K, McNally RJ. Is premenstrual dysphoria a variant of panic disorder? A review. Clin Psychol Rev. 2004;24(8):933-56.10.1016/S0272-7358(04)00102-3Search in Google Scholar

11. Le Melledo JM, Bradwejn J, Koszycki D, Bichet D. Premenstrual dysphoric disorder and response to cholecystokinin-tetrapeptide. Arch Gen Psychiatry. 1995;52(7):605-6.10.1001/archpsyc.1995.03950190087012Search in Google Scholar

12. Le Melledo J, Van Driel M, Coupland NJ, Lott P, Jhangri GS. Response to flumazenil in women with premenstrual dysphoric disorder. Am J Psychiatry. 2000;157(5):821-3.10.1176/appi.ajp.157.5.821Search in Google Scholar

13. Adewuya AO, Loto OM, Adewumi TA. Premenstrual dysphoric disorder amongst Nigerian university students: prevalence, comorbid conditions, and correlates. Arch Womens Ment Health. 2008;11(1):13-8.10.1007/s00737-008-0213-4Search in Google Scholar

14. Schwartz GE, Goetz RR, Klein DF, Endicott J, Gorman JM. Tidal volume of respiration and “sighing” as indicators of breathing irregularities in panic disorder patients. Anxiety. 1996;2(3):145-8.10.1002/(SICI)1522-7154(1996)2:3<145::AID-ANXI6>3.0.CO;2-OSearch in Google Scholar

15. Harrison WM, Sandberg D, Gorman JM, Fyer M, Nee J, Uy J, et al. Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria. Psychiatry Res. 1989;27(2):183-92.10.1016/0165-1781(89)90133-9Search in Google Scholar

16. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini International Neuropsychiatric Interview (M.i.N.i.): the development and validation of structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33.Search in Google Scholar

17. Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health. 2003;6(3):203-9.10.1007/s00737-003-0018-4Search in Google Scholar

18. Matsumoto TH, Asakura T, Hayashi T. Biopsychosocial aspects of premenstrual syndrome and premenstrual dysphoric disorder. Gynecol Endocrinol. 2013;29(1):67-73.10.3109/09513590.2012.705383Search in Google Scholar

19. Miyaoka Y, Akimoto Y, Ueda K, Ujiie Y, Kametani M, Uchiide Y, et al. Fulfillment of the premenstrual dysphoric disorder criteria confirmed using a self-rating questionnaire among Japanese women with depressive disorders. Biopsychosoc Med. 2011 2;5:5.10.1186/1751-0759-5-5Search in Google Scholar

20. Cohen LS, Soares CN, Otto MW, Sweeney BH, Liberman RF, Harlow BL. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. J Affect Disord. 2002;70(2):125-32.10.1016/S0165-0327(01)00458-XSearch in Google Scholar

21. Sehlo MG, Youssef UM, Mahdy RS, El-Gohari H. Prevalence and symptoms of premenstrual dysphoric disorder in a sample of psychiatric patients at Zagazig University Hospitals. Egypt J Psychiatry. 2018;39(2):83-8.10.4103/ejpsy.ejpsy_36_17Search in Google Scholar

22. Halbreich U, O’Brien PM, Eriksson E, Backstrom T, Yonkers KA, Freeman EW. Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder? CNS Drugs. 2006;20(7):523-47.10.2165/00023210-200620070-00001Search in Google Scholar

23. Kim DR, Gyulai L, Freeman EW, Morrison ME, Baldassano C, Dube B. Premenstrual dysphoric disorder and psychiatric co-morbidity. Arch Womens Ment Health. 2004;7(1):37-47.10.1007/s00737-003-0027-3Search in Google Scholar

24. Breaux C, Hartlage S, Gehlert S. Relationships of premenstrual dysphoric disorder to major depression and anxiety disorders: a re-examination. J Psychosom Obstet Gynecol. 2000;21(1):17-24.10.3109/01674820009075604Search in Google Scholar

25. Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. a randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group. JAMA. 1997;278(12):983-8.10.1001/jama.1997.03550120043031Search in Google Scholar

26. Landen M, Nissbrandt H, Allgulander C, Sörvik K, Ysander C, Eriksson E. Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder. Neuropsychopharmacology. 2007;32(1):153-61.10.1038/sj.npp.1301216Search in Google Scholar

27. Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRis. J Womens Health (Larchmt). 2006;15(1):57-69.10.1089/jwh.2006.15.57Search in Google Scholar

28. Steiner M, Romano SJ, Babcock S, Dillon J, Shuler C, Berger C, et al. The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder. BJOG. 2001;108(5):462-8.10.1111/j.1471-0528.2001.00120.xSearch in Google Scholar

29. Dimmock PW, Wyatt KM, Jones PW, O’Brien PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome : asystematic review. The Lancet. 2000;356(9236):1131-6.10.1016/S0140-6736(00)02754-9Search in Google Scholar

30. O’Brien PM, BackstromT, Brown C, Dennerstein L, Endicott J, Epperson CN, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011;14(1):13-21.10.1007/s00737-010-0201-3413492821225438Search in Google Scholar

31. Walsh S, Ismaili E, Naheed B, O’Brien S. Diagnosis, pathophysiology and management of premenstrual syndrome. Obstet Gynaecol. 2015;17:99-104.10.1111/tog.12180Search in Google Scholar

32. Marjoribanks J, Brown J, O’Brien PM, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2013;7(6):CD001396.10.1002/14651858.CD001396.pub3707341723744611Search in Google Scholar

eISSN:
1313-9053
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Medicine, Clinical Medicine, other, Ophthalmology, Public Health, Pharmacy, Clinical Pharmacy